From: Prescription practices and availability of artemisinin monotherapy in India: where do we stand?
Drug group/treatment | n | % | PQ | Abx |
---|---|---|---|---|
Artemisinin monotherapy | 271 | 14.8 | 6 | 75 |
Non-artemisinin monotherapy | 1, 241 | 68.0 | 520 | 98 |
Chloroquine | 1155 | Â | 520 | 74 |
Primaquine | 5 | Â | Â | Â |
Quinine | 74 | Â | Â | 24 |
SP | 7 | Â | Â | Â |
WHO ACT | 89 | 4.9 | 37 | 2 |
ASP blister | 30 | Â | Â | 2 |
ASP loose | 16 | Â | 5 | Â |
ASP+CQ | 37 | Â | 31 | Â |
ASP+Q | 3 | Â | 1 | Â |
ASP+CQ+Q | 3 | Â | Â | Â |
Non-WHO ACT | 102 | 5.6 | 8 | 35 |
As+CQ | 63 | Â | 7 | 19 |
As+Q | 37 | Â | Â | 15 |
As+CQ+Q | 2 | Â | 1 | 1 |
Non-artemisinin combination | 15 | 0.8 | 7 | 0 |
CQ+SP | 13 | Â | 7 | Â |
CQ+Q | 2 | Â | Â | Â |
No anti-malarial drug | 108 | 5.9 | 0 | 23 |
Missing | 6 | Â | Â | Â |
 | 1832 |  | 583 | 233 |